Kimball J - Search Results

1

Early use of OKT3 monoclonal antibody in renal transplantation to prevent rejection.

Norman DJ, Shield CF 3rd, Barry J, Bennett WM, Henell K, Kimball J, Funnell B, Hubert B. Norman DJ, et al. Among authors: kimball j. Am J Kidney Dis. 1988 Feb;11(2):107-10. doi: 10.1016/s0272-6386(88)80190-2. Am J Kidney Dis. 1988. PMID: 3277400 Clinical Trial.

2

OKT3 for induction immunosuppression in renal transplantation: a comparative study of high versus low doses.

Norman DJ, Barry JM, Bennett WM, Munson JL, Meyer M, Henell K, Kimball J, Hubert B. Norman DJ, et al. Among authors: kimball j. Transplant Proc. 1991 Feb;23(1 Pt 2):1052-4. Transplant Proc. 1991. PMID: 1846453 No abstract available.

3

Monoclonal antibody OKT3 therapy in pediatric kidney transplant recipients.

Leone MR, Barry JM, Alexander SR, Melvin T, Striegel J, Reller K, Henell KR, Kimball J, Funnell MB, Goldstein G, et al. Leone MR, et al. Among authors: kimball j. J Pediatr. 1990 May;116(5):S86-91. doi: 10.1016/s0022-3476(05)82708-8. J Pediatr. 1990. PMID: 2139465

4

Effectiveness of a second course of OKT3 monoclonal anti-T cell antibody for treatment of renal allograft rejection.

Norman DJ, Shield CF 3rd, Henell KR, Kimball J, Barry JM, Bennett WM, Leone M. Norman DJ, et al. Among authors: kimball j. Transplantation. 1988 Oct;46(4):523-9. doi: 10.1097/00007890-198810000-00011. Transplantation. 1988. PMID: 3140448

5

A prospective, double-blind, randomized study of high-versus low-dose OKT3 induction immunosuppression in cadaveric renal transplantation.

Norman DJ, Kimball JA, Bennett WM, Shihab F, Batiuk TD, Meyer MM, Barry JM. Norman DJ, et al. Among authors: kimball ja. Transpl Int. 1994 Aug;7(5):356-61. doi: 10.1007/BF00336712. Transpl Int. 1994. PMID: 7993573 Clinical Trial.

6

Cytokine-release syndrome: differences between high and low doses of OKT3.

Norman DJ, Kimball JA, Barry JM. Norman DJ, et al. Among authors: kimball ja. Transplant Proc. 1993 Apr;25(2 Suppl 1):35-8. Transplant Proc. 1993. PMID: 8465420 Clinical Trial. No abstract available.

7

OKT3 antibody response study: comparative testing of human antimouse antibody.

Kimball JA, Norman DJ, Shield CF, Schroeder TJ, Lisi P, Garovoy M, O'Connell JB, Stuart F, McDiarmid SV, Wall W. Kimball JA, et al. Transplant Proc. 1993 Apr;25(2 Suppl 1):74-6. Transplant Proc. 1993. PMID: 8465432 No abstract available.

8

The OKT3 Antibody Response Study: a multicentre study of human anti-mouse antibody (HAMA) production following OKT3 use in solid organ transplantation.

Kimball JA, Norman DJ, Shield CF, Schroeder TJ, Lisi P, Garovoy M, O'Connell JB, Stuart F, McDiarmid SV, Wall W. Kimball JA, et al. Transpl Immunol. 1995 Sep;3(3):212-21. doi: 10.1016/0966-3274(95)80027-1. Transpl Immunol. 1995. PMID: 8581409 Clinical Trial.

9

Degree of modulation of cell-surface CD3 by anti-lymphocyte therapies.

Henell KR, Bakke A, Kenny TA, Kimball JA, Barry JM, Norman DJ. Henell KR, et al. Among authors: kimball ja. Transplant Proc. 1991 Feb;23(1 Pt 2):1070-1. Transplant Proc. 1991. PMID: 1824886 No abstract available.

10

OKT3 antibody response study (OARS): a multicenter comparative study.

Kimball JA, Norman DJ, Shield CF, Schroeder TJ, Lisi P, Garovoy M, O'Connell JB, Stuart F, McDiarmid SV, Wall W. Kimball JA, et al. Transplant Proc. 1993 Feb;25(1 Pt 1):558-60. Transplant Proc. 1993. PMID: 8438413 Clinical Trial. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

306 results

Search Page

Filters